Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.
Nature. 2019 Dec;576(7787):471-476. doi: 10.1038/s41586-019-1821-z. Epub 2019 Dec 11.
Nature. 2019.
PMID: 31827283
Free PMC article.